Florence accelerates clinical research with innovative solutions to streamline clinical trial site workflows and remote connect sponsors, CROs, and sites for access, monitoring, management, and SDR/V. The Florence platform is the industry standard with more than 7,200 research sites in 27 countries, sponsors and CROs collaborating on its network.

Research study sites manage their internal document operations with the #1 Electronic Investigator Site File with solutions across eRegulatory, Source Capture, eConsent, eLogs, Contract Management, SOP Management, and Remote Access.

Sponsors and CROs gain unprecedented remote access to their study sites for remote startup, monitoring, and SDV built on the industry-standard remote site access platform.


Florence eTMF is designed to give you all the capabilities you need in an intuitive and flexible interface. Plus, you get remote digital connection to 7,200 research sites managing their eISF on our network, with the ability to deploy the #1 digital site workspace to all of your study sites.

Successful clinical trials require remote site access and collaboration. We’ve got you covered. Florence eHub gives Sponsors and CROs direct digital access to the network of 7,200+ Investigator sites across 26 countries managing their eISF on our platform. Plus, our expert site digital transformation team works with you to get your other sites online fast – in as little as three days.

Florence eBinders integrates all of your clinical trial systems, automates eRegulatory processes, reduces contract negotiation time, tracks study progress, and enables secure remote monitoring on the industry-standard eRegulatory, eISF, and eSource platform.


Florence Healthcare

600 Peachtree St. NE, Suite 920

Atlanta, GA 30308


Phone: 706-768-2196

Contact: Blake Adams


  • In this article, read how the explosion in remote clinical trial technology over the past two years has changed how clinical research teams work together. 

  • Sponsors, CROs, and research sites in the U.S. have always understood the importance of the FDA approval process. But with the arrival of COVID-19 vaccines, the general public has started paying closer attention to the FDA’s actions. 

  • “Within hours, our clinical operations had to be fully remote. Patients couldn’t come on-site. Our team couldn’t get into the clinic. But we had to keep our studies on track and needed to continue to monitor patient safety,” says Catherine Gregor, Director of Clinical Research Administration for Vanderbilt-Ingram Cancer Center.

  • Many sites in the current pandemic landscape have limited or restricted on-site monitoring visits, increasing the demand for remote site access solutions across the industry. Read how the accelerating digital transformation stems from sponsors and CROs needing access to essential regulatory documents and source data from their sites.

  • Shifting to remote processes is part of a broader healthcare trend but moving away from paper is very specific to clinical research. Most of the healthcare industry has already made this transition. To be successful, you need to go all-in on technology adoption, and it cannot be single-threaded or incremental. Organizations looking to create an effective environment for technology transformation can help make the process more seamless by taking into account three key considerations we cover in this blog.

  • Workflow software has the power to literally shift space and time. In this article we share some examples of how software can expand access for any process and describe specific applications and benefits for clinical research.

  • The COVID-19 pandemic proved that patients can participate in clinical trials using video calls, apps, wearable devices, and visits to their local physician, not just by visiting the research site in person. However, these hybrid decentralized trials work best when there are software integrations between research sites and their sponsors. So how do you set up the site-sponsor connection and make decentralized trials effective and secure?

  • While personal health information protections have been established for decades, today’s booming rate of technology adoption and complexity of data flows has created a new demand for how patient and participant data is collected, stored and shared among sites, sponsors, CROs, internal and external stakeholders. Now as we rapidly shift towards remote-enabled technology it is critical to understand how this regulation will impact your organization. The first step is understanding the basics.

  • Because decentralized clinical trials use technology to share data remotely, decentralized trials can’t succeed without the right software. But with dozens of clinical research platforms flooding the market, it keeps getting harder to figure out what they all do and which ones you need.

  • When we talk about decentralized clinical trials, we mean using technology to give patients easier access to research sites in their local area. This sounds great for patients, but how does it work for research sites? Here are five impacts clinical research sites can expect to see as decentralized trials become more common.

  • The concept of decentralized clinical trials is not new, but in response to COVID disruptions, research operations leaders were forced in 2020 to accelerate their plans for remote and virtual trials. In response, decentralized clinical trials have become a primary innovation in the clinical operations ecosystem. But the meaning of the term “decentralized clinical trials” is not universally understood.

  • The failure to prioritize the TMF can leave sponsors and clinical research organizations (CROs) to appear disorganized, delay clinical trial completion, and, in the worst cases, fail at bringing treatments to market. Sholeh Ehdaivand, president and CEO of LMK Clinical Research Consulting, discusses the Trial Master Files (TMF) and its pivotal role in the future of real-time collaboration between clinical research sites and sponsors.

  • Remote site access is now a requirement for clinical trial operations. As you seek to transform your monitoring strategy and build your virtual toolkit, you must must be familiar with the capabilities available. The failure of a remote site access solution will result in disrupted site workflows, increased compliance risk, and ultimately delayed study timelines. The Florence team put together this list of requirements most sponsors and CROs look for in their selection process to help you make an informed investment in this new technology category.

  • Biotech companies starting their first few clinical trials typically do not have the resources to host an eTMF in-house. For this reason, they often outsource to a Clinical Research Organization (CRO) and use the CRO’s applicable software. If the study is successful and moves to subsequent phases, or if Biotech adds new studies to their portfolio, hosting the eTMF with subcontractors limits the Biotech from moving operations in-house or engaging new CROs. Continue reading to learn more reasons why Biotech companies are bringing their eTMF in house even if they outsource services to subcontractors.

  • The COVID-19 pandemic has accelerated the ongoing shift to remote clinical trial monitoring. In this article, we explore challenges of traditional monitoring, benefits of remote clinical trial monitoring, how to deploy remote clinical trial monitoring, sponsor-deployed remote monitoring technology, and site-procured remote monitoring technology.

  • How are clinical operations leaders making strategic technology investments in 2021 and beyond? This report provides insights from more than 200 respondents to the annual Florence State of the Industry Survey, from dozens of stakeholders who are members of the Florence Executive Advisory Board, and more than 8,500 study sites and more than 8,000 sponsors using Florence.

  • Sites, sponsors, and CROs now perform the bulk of their clinical trial operations by logging into cloud-based systems. Direct digital connectivity and collaboration access with your sites, via connecting to the largest Electronic Investigator Site Files (eISF) in research, eliminates clinical trial bottlenecks.

  • In a world with more data and less time, the advantages of cloud-based technologies are hard to ignore. Debunk some of the common misconceptions of managing clinical research documents, data and workflows in a cloud-based technology platform.

  • Today’s modern clinical trial requires robust and purpose-built eClinical solutions. One of the essential capabilities you must ensure exists is the ability to integrate with other systems through Open APIs.

  • Sponsors and CROs’ ability to access and collaborate with a research site is essential to the success of every study. As study sites “come on-line,” Sponsors and CROs are in a unique position to harness this digitally connected network of sites to turn on remote site access and Source document review/verification (SDR/V), and streamline workflows. In this article, we examine the key quality outcomes and technology recommendations associated with digitally accessing the site eISF.